JYNT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

9.185

Open

9.080

VWAP

8.85

Vol

86.86K

Mkt Cap

123.99M

Low

8.690

Amount

769.10K

EV/EBITDA(TTM)

43.01

Total Shares

14.27M

EV

103.22M

EV/OCF(TTM)

25.41

P/S(TTM)

2.29

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Show More

Events Timeline

(ET)

2026-05-07

17:30:00

The Joint Corp. Q1 Revenue $14.82M, Exceeds Expectations

2026-05-07

17:30:00

Company Expects 30 to 35 New Franchise Clinics Openings

2026-04-27 (ET)

2026-04-27

16:30:00

Joint Corp. Sells 45 Clinics to Elite Chiro Group for $2.3M

2026-03-12 (ET)

2026-03-12

16:50:00

Company Reports Q4 Revenue of $15.17M, Beating Expectations

2025-11-06 (ET)

2025-11-06

17:01:00

Joint Corp. unveils new $12M stock buyback initiative

News

seekingalpha

04-27seekingalpha

The Joint Sells Southern California Clinics to Elite Chiro Group

PRnewswire

04-14PRnewswire

Nation's Largest Chiropractic Network Welcomes New Executive

Newsfilter

04-14Newsfilter

New Executive Joins Largest Chiropractic Care Network for Growth

PRnewswire

04-07PRnewswire

Miller Subaru Partners with The Joint to Enhance Employee Wellness Benefits

Newsfilter

04-07Newsfilter

Miller Subaru Partners with The Joint to Enhance Employee Wellness Benefits

seekingalpha

03-13seekingalpha

The Joint Corp. Q4 2025 Earnings Call Insights

5 Analyst Rating

Wall Street analysts forecast JYNT stock price to rise

2 Buy

3 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

9.00

Averages

11.33

High

14.00

Current: 0.000

Low

9.00

Averages

11.33

High

14.00

Roth Capital

Buy

downgrade

$14 -> $12

AI Analysis

2026-03-13

Reason

Roth Capital

Price Target

$14 -> $12

AI Analysis

2026-03-13

downgrade

Buy

Reason

Roth Capital lowered the firm's price target on Joint Corp. to $12 from $14 and keeps a Buy rating on the shares. The company's Q4 results exceeded estimates while its 2026 guidance largely mirrors the firm's model, the analyst tells investors in a research note. Roth adds, however, that the management's post-refranchising pro forma model is "underwhelming", even though it continues to see significant long-term upside.

B. Riley

B. Riley

Buy -> Neutral

downgrade

$18 -> $9

2025-11-07

Reason

B. Riley

B. Riley

Price Target

$18 -> $9

2025-11-07

downgrade

Buy -> Neutral

Reason

B. Riley downgraded Joint Corp. to Neutral from Buy with a price target of $9, down from $18. The company's Q3 comps were down 2.0%, reflecting continued softness in new patient acquisition, the analyst tells investors in a research note. The firm Joint's fiscal 2025 as "transitional," as the company tests initiatives and completes refranchising. It cites deteriorating trends for the downgrade.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for JYNT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Joint Corp (JYNT.O) is 20.96, compared to its 5-year average forward P/E of 106.93. For a more detailed relative valuation and DCF analysis to assess Joint Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

106.93

Current PE

20.96

Overvalued PE

207.49

Undervalued PE

6.37

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

30.54

Current EV/EBITDA

25.42

Overvalued EV/EBITDA

59.04

Undervalued EV/EBITDA

2.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

3.67

Current PS

2.17

Overvalued PS

7.50

Undervalued PS

-0.17

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

us stock are fine.

Intellectia · 791 candidates

Region: USPrice: >= $-100.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $-3.00Ema 20: >= -100One Week Rise Prob: >= 55

Ticker

Name

Market Cap$

Neuronetics Inc

98.80M

Maximus Inc

3.77B

FutureFuel Corp

184.67M

SOPHiA GENETICS SA

378.41M

Artesian Resources Corp

334.83M

Sweetgreen Inc

816.13M

low float medical tech stock

Intellectia · 68 candidates

Market Cap: 50.00M - 5.00BSector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchRegion: USPrice: $1.00 - $50.00Beta: ModerateRisk, HighRisk, LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000Floating Shares: <= 20,000,000

Ticker

Name

Market Cap$

Xilio Therapeutics Inc

50.19M

Lipocine Inc

54.02M

LifeVantage Corp

54.88M

Clene Inc

63.49M

Outset Medical Inc

64.46M

Adicet Bio Inc

64.58M

predict biggest winner ticker this year

Intellectia · 73 candidates

Market Cap: 100.00M - 30.00BBeta: HighRiskList Exchange: XNYS, XNAS, XASEOne Month Rise Prob: >= 55One Month Predict Return: >= 10.0%

Ticker

Name

Market Cap$

Jumia Technologies AG

1.14B

Lennox International Inc

19.72B

Dave Inc

2.39B

Comstock Inc

196.99M

Super Micro Computer Inc

18.29B

FTC Solar Inc

141.78M

Whales Holding JYNT

Trading Trends

People Also Watch

Frequently Asked Questions

What is Joint Corp (JYNT) stock price today?

The current price of JYNT is 8.69 USD — it has increased 0.23

What is Joint Corp (JYNT)'s business?

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

What is the price predicton of JYNT Stock?

Wall Street analysts forecast JYNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JYNT is11.33 USD with a low forecast of 9.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Joint Corp (JYNT)'s revenue for the last quarter?

Joint Corp revenue for the last quarter amounts to 14.82M USD, increased 13.33

What is Joint Corp (JYNT)'s earnings per share (EPS) for the last quarter?

Joint Corp. EPS for the last quarter amounts to 0.09 USD, increased 80.00

How many employees does Joint Corp (JYNT). have?

Joint Corp (JYNT) has 202 emplpoyees as of May 11 2026.

What is Joint Corp (JYNT) market cap?

Today JYNT has the market capitalization of 123.99M USD.